Clinical Trial Update: A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ASN008 for anti-pruritic effects in adults with mild to moderate atopic dermatitis completed, with results posted in December 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ASN008

Snippet

Sponsor: Formation Bio, Inc. | Conditions: Dermatitis, Atopic, Pruritus | Phase 2 | Status: COMPLETED | Results posted: 2024-12-27